Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Viridian Therapeutics (VRDN)
NASDAQ:VRDN
RESEARCH TOOLSreports
Viridian Therapeutics (VRDN) Ownership - Who Owns Viridian Therapeutics?
981 Followers
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Jan 24, 2024 | Fairmount Funds Management Llc Director, >10% Owner,other | Bought | $9999990 |
| Apr 12, 2023 | Scott Dunseth Myers Ceo,director | Bought | $101440 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2023 | Bought | $37684017 | |
| Dec 31, 2023 | Bought | $50656816 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,420,104 | Institution | 5.45% | 59,886,021 | |
| 2,934,964 | Institution | 4.68% | 51,391,220 | |
| 2,472,325 | Institution | 3.94% | 43,290,411 | |
| 2,325,841 | Institution | 3.71% | 40,725,476 | |
| 2,237,629 | Insider | 3.56% | 39,180,884 | |
| 2,034,907 | Institution | 3.24% | 35,631,222 | |
| 2,007,946 | Institution | 3.20% | 35,159,134 | |
| 1,978,582 | Institution | 3.15% | 34,644,971 | |
| 1,847,752 | Institution | 2.94% | 32,354,138 | |
| 1,730,212 | Institution | 2.76% | 30,296,012 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,472,325 | Institution | 3.94% | 43,290,411 | |
| 2,034,907 | Institution | 3.24% | 35,631,222 | |
| 1,847,752 | Institution | 2.94% | 32,354,138 | |
| 957,805 | Institution | 1.53% | 16,771,166 | |
| 553,542 | Institution | 0.88% | 9,692,520 | |
| 491,684 | Institution | 0.78% | 8,609,387 | |
| 458,265 | Institution | 0.73% | 8,024,220 | |
| 401,927 | Institution | 0.64% | 7,037,742 | |
| 260,700 | Institution | 0.42% | 4,564,857 | |
| 251,903 | Institution | 0.40% | 4,410,822 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,367,996 | Institution | 5.37% | 58,502,091 | |
| 1,782,389 | Institution | 2.84% | 33,348,498 | |
| 1,212,305 | Institution | 1.93% | 21,227,461 | |
| 816,470 | Institution | 1.30% | 15,276,154 | |
| 339,804 | Institution | 0.54% | 5,949,968 | |
| 259,620 | Institution | 0.41% | 4,509,599 | |
| 180,898 | Institution | 0.29% | 3,167,524 | |
| 155,378 | Institution | 0.25% | 2,907,122 | |
| 142,070 | Institution | 0.23% | 2,658,130 | |
| 107,985 | Institution | 0.17% | 1,890,817 |
FAQ
Who Owns Viridian Therapeutics (VRDN)?
Currently, no data Available
What percentage of Viridian Therapeutics (VRDN) stock is held by institutional investors?
Currently, no data Available
What percentage of Viridian Therapeutics (VRDN) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Viridian Therapeutics (VRDN)?
SPDR owns the most shares of Viridian Therapeutics (VRDN).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.